Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Activation of LXR?/? by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activation of LXR?/? by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.
Activation of LXR?/? by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer. BMC Cancer. 2018 Dec 10; 18(1):1232.
View in:
PubMed
subject areas
Ascites
Cholesterol
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Female
Humans
Kaplan-Meier Estimate
Liver X Receptors
Tumor Cells, Cultured
Tumor Microenvironment
authors with profiles
Danny N Dhanasekaran